1. Home
  2. JFIN vs STIM Comparison

JFIN vs STIM Comparison

Compare JFIN & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JFIN

Jiayin Group Inc.

HOLD

Current Price

$1.44

Market Cap

113.6M

Sector

Finance

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$3.03

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFIN
STIM
Founded
2011
2003
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
113.6M
120.4M
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
JFIN
STIM
Price
$1.44
$3.03
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
60.5K
1.4M
Earning Date
06-03-2026
05-05-2026
Dividend Yield
17.47%
N/A
EPS Growth
N/A
57.25
EPS
N/A
N/A
Revenue
N/A
$52,776,000.00
Revenue This Year
N/A
$11.10
Revenue Next Year
N/A
$11.92
P/E Ratio
$1.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$0.80
52 Week High
$11.77
$3.44

Technical Indicators

Market Signals
Indicator
JFIN
STIM
Relative Strength Index (RSI) 19.67 61.70
Support Level N/A $1.21
Resistance Level $2.55 N/A
Average True Range (ATR) 0.16 0.18
MACD -0.06 -0.04
Stochastic Oscillator 2.26 72.90

Price Performance

Historical Comparison
JFIN
STIM

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: